Vimarsana
Biggest News Aggregation in the World

Page 4 - Csl Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Csl Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Csl Ltd Today - Breaking & Trending Today

Australia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines - Vimarsana News

Australia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines

Asia PacificAustralia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines Reuters 3 minute read CSL Ltd (CSL.AX) said on Thursday it does not have the capacity to simultaneously produce AstraZeneca (AZN.L) and Novavax Inc's (NVAX.O) COVID-19 vaccines after a local report said the U.S.-based firm was looking for an Australian manufacturing partner. Australian biotech CSL is already under contract to locally make 50 million doses of the AstraZeneca vaccine, and is currently churning out more than a million doses a week. read more Australia is relying on deliveries from Pfizer (P...

Outlook on the Biologic Therapeutic Drugs Global Market to 2025 - Growing Geriatric Population is Driving the Industry - Vimarsana News

Outlook on the Biologic Therapeutic Drugs Global Market to 2025 - Growing Geriatric Population is Driving the Industry

Share this article Share this article ResearchAndMarkets.com's offering. The current report offers a detailed picture of the biologics market. This report highlights the current and future market potential for biologics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players. This report details market shares for biologics based on product and geography. Based on product, the market is segmented into therapeutic protei...

CSL (ASX:CSL) share price pops on increased dividend - Vimarsana News

CSL (ASX:CSL) share price pops on increased dividend

The CSL (ASX: CSL) share price is higher today after the biotech announced a dramatic lift in profits and boosted dividend for the half-year.

The Latest: Fauci: Virus shot categories to open up by April - Vimarsana News

The Latest: Fauci: Virus shot categories to open up by April

MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown...

The Latest: Portugal starts giving firefighters vaccine jabs - Vimarsana News

The Latest: Portugal starts giving firefighters vaccine jabs

MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown...

Source: sfgate.com